Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. 1994

S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
Pediatric Branch, National Cancer Institute, Bethesda, MD 20892.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D017239 Paclitaxel A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death. 7-epi-Taxol,Anzatax,Bris Taxol,NSC-125973,Onxol,Paclitaxel, (4 alpha)-Isomer,Paxene,Praxel,Taxol,Taxol A,7 epi Taxol,NSC 125973,NSC125973,Taxol, Bris

Related Publications

S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
January 1983, Cancer treatment reports,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
November 1992, Investigational new drugs,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
January 1988, Medical and pediatric oncology,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
January 1996, The Journal of infusional chemotherapy,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
June 1987, Cancer treatment reports,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
September 1986, Cancer,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
September 1986, Cancer treatment reports,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
November 1999, Clinical therapeutics,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
August 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S L Berg, and K H Cowan, and F M Balis, and J S Fisherman, and A M Denicoff, and M Hillig, and D G Poplack, and J A O'Shaughnessy
August 1980, The American journal of medicine,
Copied contents to your clipboard!